Trials / Completed
CompletedNCT01390012
Oral Versus Intravenous Dexamethasone
Oral Versus Intravenous Dexamethasone in Community-Acquired Pneumonia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- St. Antonius Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess bioequivalence for dexamethasone administered orally versus intravenously in patients admitted to hospital for pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone tablet 6 mg | Dexamethasone tablet 6 mg |
| DRUG | Dexamethasone injection 4 mg | Dexamethasone injection 4 mg |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2011-07-08
- Last updated
- 2014-01-15
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01390012. Inclusion in this directory is not an endorsement.